Therapeutic Botulinum Toxin – Market Insights – Global
Despite the negative impact of the COVID-19 pandemic, the global market for therapeutic BTX will exhibit rapid growth through 2031. The need to return for maintenance procedures will sustain demand among existing patients, while rising demand driven by expanding indications will fuel procedure volume growth over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, Europe, and Asia Pacific region from 2019 through 2031.
The COVID-19 pandemic has had a significant impact on the global therapeutic BTX market in the short-term.
How and to what extent has the COVID-19 pandemic impacted the therapeutic BTX market globally?
Which geographies and segments have experienced the largest impact?
When will market recover to pre-pandemic growth patterns?
New indication approvals and existing indication expansions will be significant drivers in the therapeutic BTX market.
Which indications contribute the most to growth?
What regional differences exist regarding indication approvals?
What new indications have the largest market potential?
Which competitors have been targeting these indications?
Global therapeutic BTX markets are becoming more and more consolidated.
What are some key competitive strategies being employed to succeed in the market?
How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?
Markets vary greatly by region in terms of size and growth, with the US market experiencing the fastest expansion globally.
What key drivers contribute to a market's relative size and growth?
What factors most significantly affect pricing within markets?
Table of contents
- Therapeutic Botulinum Toxin - Market Insights - Global
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Factors Impacting the Therapeutic BTX Market, Global
- Therapeutic BTX Market, by Region, Global (USD), 2019u20132031
- Therapeutic BTX Market Landscape, Global (USD), 2021 and 2031
- Competitive Highlights
- Competitive Factors and Strategies, by Region
- Therapeutic BTX Revenue Market Share Rankings, by Region, Global, 2021
- Companies Mentioned
- Market Developments
- Recent Events in the Therapeutic BTX Market, Global
- Key Clinical Trials in the Therapeutic BTX Market, Global
- Emerging Products for the Therapeutic BTX Market, Global
- Geographies Covered
- Geographies Covered, Global
- Average Currency Exchange Rates
- Procedures Covered
- Therapeutic BTX Procedures Covered, US
- Approved Indications, by Brand, US, 2021/2022
- Therapeutic BTX Procedures Covered, Europe
- Approved Indications, by Brand, Europe, 2021/2022
- Therapeutic BTX Procedures Covered, Asia Pacific
- Approved Indications, by Brand, Asia Pacific, 2021/2022
- Products Covered
- Therapeutic BTX Product Overview, Global, 2021/2022
- COVID-19 Updates
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Therapeutic BTX Market, Global
- Major Market Forecast Changes and Assumptions
- Therapeutic BTX Market, by Region, Global (USD), 2019u20132031 (Excluding COVID-19 Impact)
- Therapeutic BTX Market, by Region, Global (USD), 2019u20132031 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Therapeutic BTX Market, Global
- COVID-19 Financial Impact and Competitor Insights
- Market Impact
- Global Therapeutic Botulinum Toxin Market
- Market Highlights
- Factors Impacting the Therapeutic BTX Market, Global
- Therapeutic BTX Market, by Region, Global (USD), 2019u20132031
- Market Definitions
- Therapeutic BTX Product Overview, Global, 2021/2022
- Mean Dosages, by Indication and Brand, Global
- BTX Units Used per Procedure, by Indication, Global
- BTX Product Equivalencies, by Brand
- Approved Indications, by Brand, US, 2021/2022
- Approved Indications, by Brand, Europe, 2021/2022
- Approved Indications, by Brand, Asia Pacific, 2021/2022
- Market Forecast Data
- Therapeutic BTX Procedures, by Indication, Global, 2019u20132031
- Therapeutic BTX Procedures, by Region, Global, 2019u20132031
- Therapeutic BTX Market, by Indication, Global (USD), 2019u20132031
- Therapeutic BTX Market, by Region, Global (USD), 2019u20132031
- Therapeutic BTX Market Growth, by Region, Global, 2021u20132031
- Competitive Highlights
- Market Shares
- Therapeutic BTX Revenue Market Shares, Global, 2021
- Therapeutic BTX Revenue Market Shares, by Region, Global, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Region
- Market Developments
- Recent Events in the Therapeutic BTX Market, Global
- Key Clinical Trials in the Therapeutic BTX Market, Global
- Emerging Products for the Therapeutic BTX Market, Global
- Market Highlights
- US Therapeutic Botulinum Toxin Market
- Market Highlights
- Therapeutic BTX Market, US (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Therapeutic BTX Procedures, by Indication, US, 2019u20132031
- Spasticity Therapeutic BTX Procedures, by Anatomy, US, 2019u20132031
- Spasticity Therapeutic BTX Procedures, by Age Group, US, 2019u20132031
- Overactive Bladder Therapeutic BTX Procedures, by Cause, US, 2019u20132031
- Therapeutic BTX Market, by Indication, US (USD), 2019u20132031
- Therapeutic BTX Market, US (USD), 2019u20132031
- Competitive Highlights
- Market Shares
- Therapeutic BTX Revenue Market Shares, US 2021
- Therapeutic BTX Revenue Market Shares, US, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, US
- Market Highlights
- European Therapeutic Botulinum Toxin Market
- Market Highlights
- Therapeutic BTX Market, by Country, Europe (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Therapeutic BTX Procedures, by Indication, Europe, 2019u20132031
- Therapeutic BTX Procedures, by Country, Europe, 2019u20132031
- Therapeutic BTX Procedures, by Indication, France, 2019u20132031
- Therapeutic BTX Procedures, by Indication, Germany, 2019u20132031
- Therapeutic BTX Procedures, by Indication, Italy, 2019u20132031
- Therapeutic BTX Procedures, by Indication, Spain, 2019u20132031
- Therapeutic BTX Procedures, by Indication, UK, 2019u20132031
- Therapeutic BTX Market, by Indication, Europe (USD and EUR), 2019u20132031
- Therapeutic BTX Market, by Country, Europe (USD), 2019u20132031
- Therapeutic BTX Market, by Country, Europe (EUR and GBP), 2019u20132031
- Therapeutic BTX Market Growth, by Country, Europe, 2021u20132031
- Therapeutic BTX Market, by Indication, France (USD and EUR), 2019u20132031
- Therapeutic BTX Market, by Indication, Germany (USD and EUR), 2019u20132031
- Therapeutic BTX Market, by Indication, Italy (USD and EUR), 2019u20132031
- Therapeutic BTX Market, by Indication, Spain (USD and EUR), 2019u20132031
- Therapeutic BTX Market, by Indication, UK (USD and EUR), 2019u20132031
- Therapeutic BTX Market, by Indication, UK (GBP), 2019u20132031
- Competitive Highlights
- Market Shares
- Therapeutic BTX Revenue Market Shares, Europe, 2021
- Therapeutic BTX Revenue Market Shares, by Country, Europe, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Country, Europe
- Market Highlights
- Asia Pacific Therapeutic Botulinum Toxin Market
- Market Highlights
- Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Therapeutic BTX Procedures, by Indication, Asia Pacific, 2019u20132031
- Therapeutic BTX Procedures, by Country, Asia Pacific, 2019u20132031
- Therapeutic BTX Procedures, by Indication, Australia, 2019u20132031
- Spasticity Therapeutic BTX Procedures, by Anatomy, Australia, 2019u20132031
- Spasticity Therapeutic BTX Procedures, by Age Group, Australia, 2019u20132031
- Overactive Bladder Therapeutic BTX Procedures, by Cause, Australia, 2019u20132031
- Therapeutic BTX Procedures, by Indication, Japan, 2019u20132031
- Therapeutic BTX Market, by Indication, Asia Pacific (USD), 2019u20132031
- Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019u20132031
- Therapeutic BTX Market, by Indication, Australia (USD), 2019u20132031
- Therapeutic BTX Market, Australia (USD), 2019u20132031
- Therapeutic BTX Market, by Indication, Japan (USD), 2019u20132031
- Therapeutic BTX Market, Japan (USD), 2019u20132031
- Competitive Highlights
- Market Shares
- Therapeutic BTX Revenue Market Shares, Asia Pacific, 2021
- Therapeutic BTX Revenue Market Shares, by Country, Asia Pacific, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Country, Asia Pacific
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Parth Gandhi is a Research Associate within the Orthopaedics, Dental, and Aesthetics Medtech Insights team at Clarivate, specializing in the aesthetics market. Parth holds a master’s degree in Pharmacy from Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Karnataka.